I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
First-in-Human Dose-Escalation Study of the Novel Oral Deps..:
Anna R. Schreiber
;
Jodi A. Kagihara
;
Bradley R. Corr
...
https://www.mdpi.com/2072-6694/16/1/91. , 2023
Link:
https://doi.org/10.3390/cancers16010091
RT Journal T1
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:451d3f14506a4c3c96f07402e100bfa1&Exemplar=1&LAN=DE A1 Anna R. Schreiber A1 Jodi A. Kagihara A1 Bradley R. Corr A1 S. Lindsey Davis A1 Christopher Lieu A1 Sunnie S. Kim A1 Antonio Jimeno A1 D. Ross Camidge A1 Jud Williams A1 Amy M. Heim A1 Anne Martin A1 John A. DeMattei A1 Nisha Holay A1 Todd A. Triplett A1 S. Gail Eckhardt A1 Kevin Litwiler A1 James Winkler A1 Anthony D. Piscopio A1 Jennifer R. Diamond PB MDPI AG YR 2023 K1 HDAC inhibitors K1 solid tumors K1 phase I clinical trial K1 MEK inhibitors K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.mdpi.com/2072-6694/16/1/91 LK http://dx.doi.org/https://doi.org/10.3390/cancers16010091 DO https://doi.org/10.3390/cancers16010091 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)